summary:
  enable: true
  icon: "fa-user"
  summary: |
    * PhD-qualified immunologist with 15 years of experience with a focus on immuno-oncology and cancer vaccines in the biotechnology environment
    * valued experience at all stages of drug development: early discovery, IND-enabling preclinics, GLP nonclinical and biomarker supports for phase II, and GMP bioassays for phase III and drug commercialization
    * h-index=18, [published 6 first author + 18 co-author manuscripts in high-impact scientific journals](https://www.ncbi.nlm.nih.gov/pubmed/?term=sebastien+wieckowski), filled 2 international patents and active reviewer in a dozen of scientific journals
    * solid expertise in immunology-based assays, animal models, molecular and cellular biology, biochemistry and flow cytometry, strong skills in data analysis and bioinformatics, and great ability to take advantage of innovative technologies, e.g., AI
    * supervised and mentored technicians, students and PhD candidates, responsible for multiple technical and IT platforms

experiences:
  enable: true
  icon: "fa-flask"

jobs:
  list:
  - position: Director Nonclinical Development
    dates: Nov 2021 — Mar 2023
    company: Worg Pharmaceuticals, Allschwil (CH) / Hangzhou (CN)
    image: 
      url: images/worg.png
      style: "flex"
    details: |
      * development of the preclinical program for our drug candidates
        * _in vitro_ and _in vivo_ pharmacology, pharmacokinetics and toxicology
        * IND-enabling GLP program from scratch for a small molecule in ophthalmology
        * extension of non-clinical package for supporting a Phase 2a clinical trial
      * EMA, FDA and CDE (China) regulatory documents: pre-IND Briefing Package, Investigator Brochure, CTD (Module 2.4), IND application
      * management of all the preclinical operations with CROs

    technos:
    - GLP
    - pharmacology
    - toxicology
    - nonclinical
    - PK/PD
    - ocular toxicity
    - juvenile toxicology
    - DART
    - nonhuman primates
    - ICH guidelines
    - FDA
    - EMA
    - CDE (China)
    - IND
    - CTD
    - PIND
    - Graves' Disease
    - allergy
    - small molecules
    - peptides

  - position: Principal Scientist
    dates: Dec 2018 — Oct 2021
    company: University of Applied Sciences (FHNW) / Roche, Basel, Switzerland
    image: 
      url: images/roche.png
      style: "flex"
    details: |
      * development of innovative bioassays in immunology and cell and gene therapy (GMP)
      * training of the technical staff in flow cytometry, and human cell biology/immunology
      * scientific and technical support in many projects

    technos:
    - GMP
    - ddPCR
    - imaging cytometry
    - multiplex
    - RNAseq
    - NK cells
    - macrophages
    - ADCC
    - ADCP
    - gene therapy
    - AAV
    - Pentraxin-2
    - gantenerumab
    - pertuzumab
    - glofitamab

  - position: Senior Scientist (part-time consulting)
    dates: Nov 2020 — Oct 2021
    company: VAXIMM AG / NEC, Basel, Switzerland
    image: 
      url: images/vaximm.png
      style: "flex"
    details: |
      * responsible for the personalized neoantigen vaccine assembly for the clinical trial NECVAXNEO1

    technos:
    - personalised medicine
    - DNA vaccine
    - glioblastoma
    - NGS
    - neoantigen discovery
    - epitope assembly
    - machine learning

  - position: Senior Scientist
    dates: Jan 2016 — Nov 2018
    company: VAXIMM GmbH, Mannheim, Germany
    image: 
      url: images/vaximm.png
      style: "flex"
    details: |
      * R&D and nonclinical development of the company's oral T cell vaccine pipeline -- VXM01, VXM04, VXM06, VXM10 and VXMNeo
      * supervision of the immunomonitoring and histopathology GCLP analyses of our phase I/II clinical trials
      * Business Development (industry, academic collaborations) and interaction with CRO partners
      * regular and active participation to our Company Board and internal meetings + international congresses

    technos:
    - DNA vaccine
    - preclinical
    - toxicology
    - angiogenesis
    - CROs
    - histology
    - bioinformatics
    - data science
    - business development
    - Investigator Brochure

  - position: Parental Leave
    dates: 2015
    company: Alsace, France
    image: 
      url: images/parental_leave.png
      style: "flex"
    details: |
      * provision of care for my baby
      * completion of a full renovation of a house within budget
        * coordination and scheduling of the activities of 10+ contractors
        * partnering with local community members to gain planning approvals
        * taking lessons to gain specific technical skills in plumbing, electricity, carpentry, floors and painting
      * updating and extending professional skills in physiology, biostatistics, and programming

    technos:
    - becoming a Great Dad
    - construction work
    - biostatistics
    - Python 3

  - position: Roche Postdoc Fellowship (RPF)
    dates: 2012 — 2015
    company: Roche Glycart / Universitätsspital Basel / Department of Biomedicine, Basel, Switzerland
    image: 
      url: images/roche.png
      style: "flex"
    details: |
      * assessment of novel tumor stroma-targeted IL-2-variant immunocytokines developped by Roche Glycart (mentor Dr. C. Klein), combined with anti-cancer therapeutics and immunomodulatory antibodies, in genetically engineered mouse models of non-small cell lung cancer
      * collaborations with Prof. Dario Neri (ETHZ), Prof. M. Pittet (MGH), CureVac (mRNA cancer vaccine phase I), and VAXIMM
      * deputy study director for animal licenses of the Cancer Immunology group (Prof. A. Zippelius)

    technos:
    - IL-2v
    - immunocytokines
    - ICIs
    - lung cancer
    - LTK2
    - GEMM
    - tumor xenografts
    - co-culture
    - IHC
    - intratracheal
    - SPECT/µCT
    - animal licenses

  - position: Maître Assistant / Lab Manager
    dates: 2007 — 2011
    company: Ludwig Institute for Cancer Research / UNIL / CHUV, Lausanne, Switzerland
    image: 
      url: images/licr.png
      style: "flex"
    details: |
      * characterization of CD8 T cell responses after therapeutic vaccination of melanoma patients with antigenic Melan-A/MART-1 peptides
      * prospective phase I clinical trial from the group of Prof. P. Romero, Prof. D. Speiser and Dr. N. Rufer
      * mentoring of students and technical staff
      * collaboration with the Molecular Modelling group of Prof. O. Michielin

    technos:
    - TCR
    - tetramers
    - flow cytometry
    - sequencing
    - RT-PCR
    - microarray
    - single cells
    - cell sorting
    - peptides
    - PBMCs
    - T cell cloning
    - CTL
    - ELISpot
    - lentivirus

  - position: Visiting scientist
    dates: 2007
    company: Faculty of Medicine RTH Laennec, Lyon, France
    image: 
      url: images/hcl.png
    details: |
      * initiation of a national project on the transduction of human DCs with adenovirus and enhanced presentation of HIV-1 epitopes; applications to the potentiation of an anti-HIV-1 response
      * continuation of a collaborative project started in Jan. 2006 with the Laboratory of Virology & Viral Pathogenesis (Prof. P. Boulanger)

    technos:
    - HIV
    - adenovirus
    - dendritic cells
    - molecular biology
    - grant

  - position: Ph.D. Student
    dates: 2003 — 2007
    company: University of Strasbourg, France
    image: 
      url: images/unistrass.png
    details: |
      * development of innovative functional CD40L mimetics based on C3-symmetric peptide scaffolds, at the interface of chemistry and biology, and applications to cancer vaccines and immunotherapy
      * lab manager in the Immunologie et Chimie Thérapeutiques (Prof. S. Müller), Institut de Biologie Moléculaire et Cellulaire (IBMC)
      * mentoring of students and technical staff

    technos:
    - apoptosis
    - confocal microscopy
    - SDS-PAGE
    - Western blot
    - 2D gel-electrophoresis
    - ELISA
    - hybridoma
    - chromatography
    - surface plasmon resonance
    - dynamic light scattering
    - organic chemistry
    - mass spectroscopy

  - position: Course Assistant
    dates: 2004 — 2007
    company: University of Strasbourg, France
    image: 
      url: images/unistrass.png
      style: "flex"
    details: |
      * course assistant in immunology "travaux pratiques" for B.Sc. biochemistry, Université Strasbourg I
      * teaching assistant in immunobiology "travaux dirigés" for first college degree in biology, Université Strasbourg I

    technos:
    - immunology
    - teaching

  - position: IT support
    dates: 2004 — 2007
    company: CNRS UPR9021, University of Strasbourg, France
    image: 
      url: images/cnrs.png
      style: "flex"
    details: |
      * IT help to all my colleagues: installation of scientific software, workshops, hardware fix (with headache), network troubleshooting
      * deployment and optimization of new hardware (computers and instruments)
    technos:
    - Windows
    - server
    - peripherals
    - network
    - installation
    - configuration
    - maintenance
    - troubleshooting

projects:
  enable: true
  icon: fa-briefcase
  list:
  - title: Publications
    tagline: |
      1. Young LE, Schnieke AE, McCreath KJ, **Wieckowski S**, Konfortova G, Fernandes K, Ptak G, Kind AJ, Wilmut I, Loi P, Feil R. -- Conservation of IGF2-H19 and IGF2R imprinting in sheep: effects of somatic cell nuclear transfer. Mech Dev. 2003; 120:1433-1442
      2. Wu W, **Wieckowski S**, Pastorin G, Benincasa M, Klumpp C, Briand JP, Gennaro R, Prato M, Bianco A. -- Targeted delivery of amphotericin B to cells by using functionalized carbon nanotubes. Angew Chem Int Ed Engl. 2005; 44:6358-6362
      3. **Wieckowski S**, Fournel S, Sun W, Trouche N, Dumortier H, Bianco A, Chaloin O, Habib M, Peter JC, Schneider P, Vray B, Toes RE, Offringa R, Melief CJ, Hoebeke J, Guichard G. -- C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L. Nat Chem Biol. 2005; 1:377-382. _Research Highlights: Drug Discovery: Immune booster. Nature. 2005; 438:132. Immunotherapy: TNFR superfamily trimers. Nat Rev Drug Discov. 2006; 5:1_
      4. Pastorin G, Wu W, **Wieckowski S**, Briand JP, Kostarelos K, Prato M, Bianco A. -- Double functionalization of carbon nanotubes for multimodal drug delivery. Chem Commun (Camb). 2006; 21:1182-1184. Recognized as within the top 50 articles published in 2006 in Chem Commun.
      5. Bianco A, Fournel S, **Wieckowski S**, Hoebeke J, Guichard G. -- Solid-phase synthesis of CD40L mimetics. Org Biomol Chem. 2006; 4:1461-1463
      6. Kostarelos K, Lacerda L, Pastorin G, Wu W, **Wieckowski S**, Luangsivilay J, Godefroy S, Pantarotto D, Briand JP, Muller S, Prato M, Bianco A. -- Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type. Nat Nanotech. 2007; 2:108-113
      7. **Wieckowski S**, Trouche N, Chaloin O, Guichard G, Fournel S, Hoebeke J. -- Cooperativity in the interaction of synthetic CD40L mimetics with CD40 and its implication in cell signaling. Biochem. 2007; 46:3482-3493
      8. Habib M, Chamekh M, Rivas MN, **Wieckowski S**, Sun W, Bianco A, Trouche N, Chaloin O, Dumortier H, Goldman M, Guichard G, Fournel S, Vray B. -- Small molecule CD40L mimetics promote control of parasitemia by enhancing CD8+ cells production of interferon-γ during experimental Trypanosoma cruzi infection. J Immunol. 2007; 178:6700-6704
      9. Trouche N, **Wieckowski S**, Sun W, Chaloin O, Briand JP, Hoebeke J, Fournel S, Guichard G. -- Small trivalent architectures mimicking homotrimers of the TNF superfamily member CD40L: delineating the relationship between structure and effector function. JACS. 2007; 129:13480-13492
      10. Rich LR, Papalia GA, Flynn PJ... **Wieckowski S**... Myszka DG. -- A global benchmark study using affinity-based biosensors. Anal Biochem. 2009; 386:194-216
      11. Partidos CD, Hoebeke J, **Wieckowski S**, Chaloin O, Bianco A, Moreau E, Briand JP, Desgranges C, Muller S. -- Immunomodulatory consequences of ODN CpG-polycation complexes. Methods. 2009; 49:328-333
      12. Jandus C, Bioley G, Dojcinovic D, Derré L, Baitsch L, **Wieckowski S**, Rufer N, Kwok WW, Tiercy JM, Luescher IF, Speiser DE, Romero P. -- Tumor antigen specific regulatory CD4 T-cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts. Cancer Res. 2009; 69:8085-8093
      13. **Wieckowski S**, Baumgaertner P, Corthésy P, Voelter V, Romero P, Speiser DE, Rufer N. -- Fine structural variations of αβTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients. J Immunol. 2009; 183:5397-5406
      14. Iancu EM, Baumgaertner P, **Wieckowski S**, Speiser DE, Rufer N. -- Profile of a serial killer: cellular and molecular approaches to study individual cytotoxic T-cells following therapeutic vaccination. J Biomed Biotech. 2011; 2011:452606
      15. Baitsch L, Baumgaertner P, Devêvre E, Raghav SK, Legat A, Barba L, **Wieckowski S**, Bouzourene H, Deplanke B, Romero P, Rufer N, Speiser DE. -- Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients. J Clin Invest. 2011; 121:2350-2360
      16. **Wieckowski S**, Speiser DE, Gupta B, Iancu EM, Baumgaertner P, Baitsch L, Michielin O, Romero R, Rufer N. -- Single cell analysis reveals similar functional competence of dominant and non-dominant CD8 T-cell clonotypes. Proc Natl Acad Sci USA. 2011; 108:15318-15323
      17. Leimgruber A, Ferber M, Irving M, **Wieckowski S**, Hussain-Kahn H, Derré L, Rufer N, Zoete V, Michielin O. -- TCRep 3D: an automated in silico approach to study the structural properties of TCR repertoires. PloS ONE. 2011; 6: e26301
      18. Lövgren T, Baumgaertner P, **Wieckowski S**, Devêvre E, Guillaume P, Luescher I, Rufer N, Speiser DE. -- Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific T cells after vaccination with low peptide dose. Cancer Immunol Immunother. 2012; 61(6):817
      19. Gupta B, Iancu EM, Gannon PO, **Wieckowski S**, Baitsch L, Speiser DE, Rufer N. -- Simultaneous coexpression of memory-related and effector-related genes by individual human CD8 T cells depends on antigen specificity and differentiation. J Immunother. 2012; 35(6):488
      20. **Wieckowski S**, Hemmerle T, Savic Prince S, Dolder Schlienger B, Hillinger S, Neri D, Zippelius A. -- Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung. Lung Cancer. 2015; 88(1):9
      21. Gannon PO, **Wieckowski S**, Baumgaertner P, Hebeisen M, Allard M, Speiser DE, Rufer N. -- Quantitative TCR avidity assessment by NTAmers reveals melanoma antigen-specific T cell repertoires enriched for high functional competence. J Immunol. 2015; 195:356
      22. Schmitz-Winnenthal FH, Hohmann N, Schmidt T, Podola L, Friedrich T, Lubenau H, Springer H, **Wieckowski S**, Breiner KM, Mikus G, Büchler MW, Keller AV, Koc R, Springfeld C, Knebel P, Bucur M, Grenacher L, Haefeli WE, Beckhove P. -- A phase 1 trial extension to assess immunologic efficacy and safety of prime -- boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer. OncoImmunology. 2018; 7(4):e1303584
      23. Kashyap AS, Fernandez-Rodriguez L, Zhao Y, Monaco G, Trefny MP, Yoshida N, Martin K, Sharma A, Olieric N, Shah P, Stanczak M, Kirchhammer N, Park SM, **Wieckowski S**, Laubli H, Zagani R, Kasenda B, Steinmetz MO, Reinecker HC, Zippelius A. -- GEF-H1 Signaling upon Microtubule Destabilization Is Required for Dendritic Cell Activation and Specific Anti-tumor Responses. Cell Rep. 2019; 28(13):3367
      24. **Wieckowski S**, Avenal C, Orjalo AV, Gygax D, and Cymer F. -- Toward a Better Understanding of Bioassays for the Development of Biopharmaceuticals by Exploring the Structure-Antibody-Dependent Cellular Cytotoxicity Relationship in Human Primary Cells. Front Immunol 2020; 11: 552596

  - title: Patents
    tagline: |
      1. Guichard G, Fournel S, Chaloin O, Trouche N, **Wieckowski S**, Hoebeke J. -- Novel multimeric CD40 ligands, method for preparing same and use thereof for preparing drugs. Brevet Français 04/13331, déposant CNRS (15/12/2004); International Application PCT/FR2005/03146 (15/12/2005); International Publication WO/2006/064133 (22/06/2006)
      2. Guichard G, Fournel S, Trouche N, **Wieckowski S**. -- Novel multimeric molecules, a process for preparing the same and the use thereof for manufacturing medical drugs. Brevet Français 07/00809, déposant CNRS (05/02/2007); International Application PCT/FR2008/000129 (04/02/2008); International Publication WO/2008/110695 (18/09/2008)

  - title: Communications (selection)
    tagline: |
      * **Wieckowski S**, Avenal C, Orjalo AV, Gygax D, and Cymer F. -- A better understanding of bioassays -- comparison of binding assays, reporter gene assays and primary cell-based assays of glycoengineered monoclonal antibodies. BEBPA's Virtual 2021 EUR Bioassay Conference. Oral presentation
      * **Wieckowski S**, Podola L, Kobl I, Smetak H, Springer M, Nugues AL, Slos P, Broadmeadow A, Chesher C, Adda Berkane A, Wei M, Breiner K, Meichle A, Breiner K, Mansour M, Beckhove P, Lubenau H.-- Modulating T cell immunity in tumors by targeting tumor-associated antigens, PD-L1 and neoantigens using a versatile live attenuated oral Salmonella DNA vaccination platform. AACR Annual Meeting, Chicago, 2018. Poster 733
      * **Wieckowski S**. -- Non-clinical safety, immunogenicity and antitumor efficacy of live attenuated Salmonella Typhimurium based oral T-cell vaccines. ASGCT 20th Annual Meeting, Washington, D.C., 2017. Oral presentation #777
      * **Wieckowski S**, Podola L, Springer M, Broadmeadow A, Stevens P, Chesher C, Adda Berkane A, Wei M, Kobl I, Meichle A, Beckhove P, Breiner K, Lubenau H. -- Non-clinical safety, immunogenicity and antitumor efficacy of live attenuated Salmonella Typhimurium-based oral T-cell vaccines VXM01m, VXM04m and VXM06m. AACR Annual Meeting, Washington, D.C., 2017. Poster 4558
      * **Wieckowski S**. --Using the immune system to treat cancer -- Could we cure cancer in the next ten years? European Health Science Match; Heidelberg (Germany), 2016. Oral presentation #85
      * **Wieckowski S**. -- Therapeutic synergism of a novel tumor stroma-targeted IL-2- variant immunocytokine with standard-of- care anti-cancer therapeutics and immunomodulatory antibodies in the genetically engineered KP mouse model of non-small cell lung cancer. Roche Symposium of the Roche Postdoc Fellowship Program; Basel, 2013. Oral presentation #216
      * **Wieckowski S**, Müller P, Freimoser-Grundschober A, Savic S, Fink Y, Karanikas V, Umana P, Pisa P, Klein C, Zippelius A. -- Therapeutic synergism of a novel tumor stroma-targeted IL-2-variant immunocytokine with standard-of-care anti-cancer therapeutics and immunomodulatory antibodies in the genetically engineered KP mouse model of non-small cell lung cancer. Roche Symposium of the Roche Postdoc Fellowship Program; Penzberg (Germany), 2012. Poster RPF ID 216
      * **Wieckowski S**, Baumgaertner P, Corthésy P, Voelter V, Romero R, Speiser D, Rufer N. -- Characterization of CD8+ T cell responses induced by vaccination with Melan-A peptides in melanoma patients. Role of Inflammation in Oncogenesis and Immune Escape in Cancer joint Keystone Symposia, Keystone, CO, 2010. Poster J5-338
      * **Wieckowski S**, Baumgaertner P, Corthésy P, Voelter V, Romero R, Speiser D, Rufer N. -- Molecular characterization of CD8+ T cell responses in melanoma patients following therapeutic peptide vaccination. 4e Journée Scientifiques du Cancéropôle Lyon Auvergne Rhône-Alpes, Archamps (France), 2009. Poster P70. **Best Poster Award** (see also [CLARA report on page 17](https://www.canceropole-clara.com/wp-content/uploads/2018/08/RA2009.pdf))
      * **Wieckowski S**, Baumgaertner P, Corthésy P, Voelter V, Romero R, Speiser D, Rufer N. -- CD8 T cell responses in melanoma patients following therapeutic peptide vaccination. 1st Swiss Immunotherapy Symposium, Lausanne (Switzerland), 2009. Oral presentation
      * **Wieckowski S**, Trouche N, Hoebeke J, Guichard G, Fournel S. -- Application of functional small synthetic CD40L mimetics to lymphoma therapy. 1st joint meeting of European National Societies of Immunology, 16th European Congress of Immunology, Paris, 2006. Poster PD-3918
      * **Wieckowski S**, Trouche N, Sun W, Chaloin O, Hoebeke J, Guichard G, Fournel S. -- Improvements of small synthetic CD40L mimetics and their effects on cell signaling. MipTec -- the 9th Leading European Drug Discovery Event, Basel, 2006. Poster P89
      * **Wieckowski S**, Trouche N, Chaloin O, Bianco A, Hoebeke J, Dumortier H, Guichard G, Fournel S. -- A synthetic multimeric ligand of CD40 is able to mimic effector functions of the natural CD40L. Congrès Annuel de la Société Française d'Immunologie, Paris, 2004. Poster P50

  - title: Congress abstracts
    tagline: |
      * **Wieckowski S**, Podola L, Smetak H, Nugues AL, Slos P, Berkane AA, Wei M, Breiner K, Meichle A, Beckhove P, Mansour M, Lubenau H. -- Modulating T cell immunity in tumors by targeting PD-L1 and neoantigens using a live attenuated oral Salmonella platform. Cancer Res. 2018; 78(13 Supplement):733-733
      * Wick W, Wick A, Sahm F, Riehl D, von Deimling A, Bendszus M, Kickingereder P, Bonekamp D, Beckhove P, Schmitz-Winnenthal FH, Jungk C, **Wieckowski S**, Podola L, Herold-Mende C, Unterberg A, Platten MJ. -- VXM01 phase I study in patients with progressive glioblastoma: Final results. J Clin Oncol. 2018; 36(15_suppl):2017-2017
      * **Wieckowski S**, Smetak H, Kobl I, Podola L, Nugues AL, Slos P, Berkane AA, Wei M, Breiner K, Meichle A, Mansour M, Schroff M, Beckhove P, Lubenau H. -- Live attenuated oral Salmonella platform for effective T- and B-cell targeting of PD-L1. J Clin Oncol. 2018; 36(5_suppl):74-74
      * **Wieckowski S**, Podola L, Springer M, Kobl I, Koob Z, Mignard C, Berkane AA, Wei M, Meichle A, Breiner K, Schroff M, Beckhove P, Lubenau H. -- Immunogenicity and antitumor efficacy of live attenuated Salmonella typhimurium-based oral T-cell vaccines VXM01m, VXM04m and VXM06m. Cancer Res. 2017; 77(13S):Abstract nr 4558
      * Wick W, Wick A, Nowosielski M, Sahm F, Riehl D, Arzt M, von Deimling A, Bendszus M, Kickingereder P, Bonekamp D, Beckhove P, Schmitz-Winnenthal FH, Jungk C, **Wieckowski S**, Herold-Mende C, Lubenau H, Unterberg A, Platten MJ. -- VXM01 phase I study in patients with resectable progression of a glioblastoma. J Clin Oncol. 2017; 35(15_suppl):2061-2061
      * **Wieckowski S**, Springer M, Podola L, Broadmeadow A, Stevens P, Chesher CJ, Berkane AA, Wei M, Meichle A, Beckhove P, Breiner K, Lubenau H. -- Non-clinical safety and antitumor efficacy of live attenuated Salmonella typhimurium-based oral T-cell vaccines VXM01m, VXM04m and VXM06m. Eur J Cancer. 2016; 69:S106
      * Guichard G, Trouche N, **Wieckowski S**, Sun W, Chaloin O, Bianco A, Hoebeke J, Schneider P, Fournel S. -- Rationally designed multivalent architectures for mimicking homotrimers of CD40L, a member of the TNF superfamily. Peptides for Youth: The Proceedings of the 20th American Peptide Symposium, Montreal (Canada), 2007. Adv Exp Med Biol. 2009; 611:355-357

  - title: Peer-reviewing
    tagline: |
      Active reviewer in Journal for ImmunoTherapy of Cancer, Cancer Immunology Immunotherapy, Journal of Cancer Research and Clinical Oncology, Cancers, Vaccines, Viruses, Biomedicines, Immuno, Journal of Clinical Medicine, Marine Drugs, Genes, Biomolecules, and International Journal of Molecular Sciences. See also records on [ORCID](https://orcid.org/0000-0001-8121-4446) and [publons](https://www.webofscience.com/wos/author/record/1951188).

qualifications:
  enable: true
  icon: fa-server
  list:
  - title: Computer skills
    tagline: |
      * excellent knowledge of Microsoft Windows and **Linux**, including [**Powershell**](https://www.udemy.com/certificate/UC-XQHGZRXT/) and [**Bash**](https://www.linkedin.com/in/sbwiecko/details/skills/=) shells, e.g., WSL2, Ubuntu, Kali
      * computer-savvy with strong programming capabilities ([**Python, R**, C++](https://www.linkedin.com/in/sbwiecko/details/skills/), BASIC); **SQL** and noSQL ([MySQL](https://www.linkedin.com/in/sbwiecko/details/skills/))
      * [**advanced Microsoft Office**](https://www.linkedin.com/in/sbwiecko/details/skills/), i.e., Word, [Excel with VBA and Python](https://www.udemy.com/certificate/UC-M3DTI3UZ/), Power BI, PowerPoint, Access with SQL, OneNote, Teams, and SharePoint; [Google Workspace](https://www.cloudskillsboost.google/profile/badges)
      * **data analysis** and visualization with **Python** [(NumPy, SciPy, pandas, matplotlib, seaborn, Bokeh, plotly, and Machine Learning with scikit-learn)](https://www.udemy.com/certificate/UC-J6XB8YWN/), **R** (RStudio and radian), and [MATLAB](https://www.linkedin.com/in/sbwiecko/details/skills/)
      * specialized tools: [Inkscape](https://www.udemy.com/certificate/UC-8f4ce3bc-f8e4-4bde-a645-494c68ca062d/), GIMP, Photoshop, Prism, FlowJo (with R), FCS Express, DIVA, Kaluza, GeneSpring, Fiji (ImageJ), Zotero, Clone Manager
      * **bioinformatics**: online tools and databases, R and Python libraries incl. Bioconductor and biopython, (sc)RNA-Seq pipelines, PyMOL
      * cloud computing on [**Google Cloud Platform**](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718): [Create and Manage Cloud Resources](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718/badges/5076130), [Perform Foundational Infrastructure Tasks in Google Cloud](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718/badges/5196304), [Perform Foundational Data, ML, and AI Tasks in Google Cloud](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718/badges/5296868)
      * collaborative/interactive working and presentations with **Jupyter notebook**, Markdown, [Dash](https://www.udemy.com/certificate/UC-79f83847-c0c1-4f0e-b5fc-b699344c0a30/) and GitLab; Visual Studio Code, Git, Docker
      * building and deployment of **full-stack websites** with [Django, HTML and CSS](https://www.linkedin.com/in/sbwiecko/details/skills/), web applications, and interactive dashboards for data visualization; design of [**GUIs** with Qt for Python and PySide6](https://www.udemy.com/course/creez-des-applications-de-bureau-avec-python-et-pyside)
      * **openBIS** digital notebook, and other data management, labbook and inventory management systems
      * solid knowledges/self-educated in **electronics**, including basics and integrated circuits, digital electronics, **microcontrollers** and microprocessors ([Arduino](https://lms.fun-mooc.fr/media/attestations/attestation_suivi_course-v1:MinesTelecom+04017+session04_c070509c782dda7606bf9c29b832722f.pdf), [Raspberry Pi](https://www.udemy.com/certificate/UC-C4QNZY9T/)) and [MicroPython](https://openbadgepassport.com/app/badge/info/593097)

  - title: Professional development and training
    tagline: |
      * [**Introduction to Molecular Modeling in Drug Discovery**](https://courses.schrodinger.com/certificates/3zbrtimtc9). Schrödinger (2023)
      * **Google Cloud Skills Boost Program**, Google (2023--2024):
        * [Google Cloud Computing Foundations: Infrastructure in Google Cloud](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718/badges/5451550)
        * [Google Cloud Computing Foundations: Cloud Computing Fundamentals](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718/badges/5393184)
        * [Introduction to Data Analytics on Google Cloud](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718/badges/5369505)
        * [Google Cloud Fundamentals for Azure Professionals: Core Infrastructure](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718/badges/5350787)
        * [Google Cloud Fundamentals for AWS Professionals](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718/badges/5324996)
        * [Google Cloud Big Data and Machine Learning Fundamentals](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718/badges/5252430)
        * [Google Cloud Fundamentals: Core Infrastructure](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718/badges/5157544)
        * [Google Cloud Essentials](https://www.cloudskillsboost.google/public_profiles/caa0e406-e2a1-47f1-b32e-0e868d7cd718/badges/5029724)
      * [**Fundation in Mathematics**](https://openbadgepassport.com/app/badge/info/622436). Cnam, Paris (2023)
      * **Mathematics for Machine Learning Specialization**: [Linear Algebra](https://coursera.org/share/14570de94eca9d5182aa5b4975b6869e), [Multivariate Calculus](https://coursera.org/share/4983985d9c9e0766582b1421bcffb2e9), and [Principal Component Analysis](https://coursera.org/share/cdbe76ff70c99fe119dc4d0a40bc66d4). Imperial College London (2019--2023)
      * [**Chemistry for higher education**](https://openbadgepassport.com/app/badge/info/593094). Université de Liège (2023)
      * [**Des probabilités à l'estimation bayésienne**](https://openbadgefactory.com/v1/assertion/4a87fbe3659a7bad9836271280cb870a8c8f8544). Centrale Nantes, France (2023)
      * [**OpenAI Python API Bootcamp**: AI, GPT3, and more](https://www.udemy.com/certificate/UC-b0ab4158-640e-4bd9-ba41-3daba632c25d/). Udemy (2023)
      * [**Quantitative Biology Workshop**](https://courses.edx.org/certificates/1f6a5ddffde247b896885934edb09352). MITx, USA (2022)
      * [**Machine learning in python** with scikit-learn](https://lms.fun-mooc.fr/media/attestations/attestation_suivi_course-v1:inria+41026+session01_4a9d614871848635f374e9527daed1ec.pdf). INRIA, France (2021)
      * [**Introduction to statistics with Python**](https://drive.google.com/file/d/1GbvrF4Vw6-bELw861x63K2yBJe1MTaiF/view). Swiss Institute of Bioinformatics, Switzerland (2021)
      * [**Docker and Singularity** for reproducible research](https://drive.google.com/file/d/1zBnssHoKfZmMfwZdkEqossxrb0HT13aW/view). Swiss Institute of Bioinformatics, Switzerland (2021)
      * [**Version Control with Git**](https://drive.google.com/file/d/1_YOXc8LZqdbx6OXXi25luYTZyjO-yVgb/view). Swiss Institute of Bioinformatics, Switzerland (2021)
      * [**Transcriptomics Analysis**](https://drive.google.com/file/d/1ySfD5y_JrKyADyVedkI5yr0nSHwpIB0N/view). Swiss Institute of Bioinformatics, Switzerland (2021)
      * **(sc)RNAseq Data Analysis**, _full semester ([CAMB714](https://diytranscriptomics.com/))_. PennVet, University of Pennsylvania, USA (2020)
      * [**SQL Fundamentals** Track](https://www.datacamp.com/profile/sbwiecko). DataCamp, Belgium (2020)
      * [**Bio-informatique pour la Génomique Médicale**](https://lms.fun-mooc.fr/media/attestations/attestation_suivi_course-v1:USPC+37028+session01_a81e721dc788ba09bf63e5a9feda69dc.pdf). CEA, Université de Paris, France (2020)
      * [**IBM Data Science**](https://www.credly.com/badges/47be9d99-0dce-4798-907b-6c36898943e1/public_url) (Methodology, SQL, Visualization, Machine Learning). IBM, USA (2019-2020)
      * [**Python for Research**](https://courses.edx.org/certificates/e37496c0e7bd4ba5bc1183880455f68b). HarvardX, USA (2018)
      * [**Introduction à la statistique avec R**](https://lms.fun-mooc.fr/media/attestations/attestation_suivi_course-v1:UPSUD+42001+session10_b53c0b9918f42204500b163c6497bf12.pdf). Faculté de Médecine, Université Paris Sud, France (2018)
      * [**Reproducible Research**: Methodological Principles for Transparent Science](https://lms.fun-mooc.fr/media/attestations/attestation_suivi_course-v1:inria+41016+session01bis_763e0e0b58a5d93f10f605d2ca08ea2e.pdf). INRIA, France (2018)
      * **SME Instrument** Applicants Training. Euresearch, Bern, Switzerland (2018)
      * [**Maîtriser le Shell Bash**](https://lms.fun-mooc.fr/media/attestations/attestation_suivi_course-v1:univ-reunion+128001+session01_849777e0e988c2836c3fb14de6663558.pdf). Université de la Réunion, France (2018)
      * [**Python 3**, from basics to advanced concepts](https://lms.fun-mooc.fr/media/attestations/attestation_suivi_course-v1:UCA+107001+session01_ab4814f53cb7861f4654508c098db77a.pdf). Université Côte d'Azur, France (2018)
      * [**Data Scientist with Python** Career Track](https://www.datacamp.com/profile/sbwiecko). DataCamp, Belgium (2017--2018)
      * [**Human histology**](https://drive.google.com/file/d/1f2-42DIbihb9zPnNhs0HSiCnY-MCr1Gc/view?usp=drive_link). Université de Médecine de Liège, Belgium (2017)
      * [**Bioinformatics**: Genomes and Algorithms](https://lms.fun-mooc.fr/media/attestations/attestation_suivi_course-v1:inria+41007+session02_aa763eec40254e5277be283dd093956b.pdf). INRIA, France (2017)
      * [**Création d'entreprises innovantes** : de l'idée à la start-up](https://lms.fun-mooc.fr/media/attestations/attestation_suivi_course-v1:umontpellier+08003+session02_18578551a98324d4599c26666b22718e.pdf). Université de Montpellier, France (2017)
      * [**LTK Module 2**](https://drive.google.com/file/d/1xwEgse98HTnCluuxT2KIP5zsDj_G9s9q/view) -- Education and Training of Persons Conducting Animal Experiments. University of Zurich, Switzerland (2012). Accreditation as Study Director (Kantonale Tierschutzfachstelle, Veterinäramt Basel-Stadt).
      * **Animal Experimentation and Small Animal Surgery** (mouse and rat). Université Strasbourg I, France (2007)
      * **Multicolor Cytometry**: Fluorescence and Compensation. Association Française de Cytométrie, Paris (2005)
      * **Proteomics**. Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France (2005)
      * **Confocal Microscopy**. Institut de Biologie Moléculaire des Plantes, Strasbourg, France (2004)
      * **Pain in Animals**. Institut de Physiologie et de Chimie Biologique, Strasbourg, France (2004)

skills:
  enable: true
  icon: fa-rocket
  list:
  - skill: immunology
    technos:
    - human PBMC
    - Ficoll
    - serum
    - MACS
    - T clones
    - DCs
    - MΦ
    - 51Cr-release
    - BATDA
    - CTL
    - lentivirus
    - pMHC multimers
    - ELISA
    - ELISpot
    - multiplex immunoassays

  - skill: cell biology
    technos:
    - flow cytometry (Fortessa, Accuri, Calibur, Array, CyAn, Gallios, Attune)
    - FACS (Ventage, Aria)
    - imaging cytometry
    - intracellular staining
    - CBA
    - transfection
    - RNAi
    - proliferation
    - cell cycle
    - apoptosis
    - adherent
    - suspension
    - 3D-culture
    - epifluorescence
    - confocal microscopy
    - time-lapse microscopy
    - live imaging
    - fluorescent IHC
    - H&E staining
    - cryosection
    - AAV

  - skill: animal experimentation
    technos:
    - injection (iv, sc, po, im, id, nas)
    - intratracheal
    - intrathoracic
    - GEMMs
    - tumor xenografts
    - tumor growth
    - survival
    - blood sampling
    - organ collection
    - lymphoid tissues
    - rodents
    - genotyping
    - SPECT/μCT (Bioscan)
    - animal licenses
  
  - skill: molecular biology
    technos:
    - (sc)RNA-Seq
    - DNA/RNA isolation
    - PCR
    - ddPCR
    - RT-PCR
    - DNA sequencing
    - TCR spectratyping
    - molecular cloning
    - recombinant proteins
    - hybridoma
    - insect cells
    - Southern blotting
    - Northern blotting
    - functional promoter
    - whole genome microarray (Agilent)

  - skill: biochemistry
    technos:
    - SPR (BIAcore3000)
    - DLS (Dynapro)
    - SDS-PAGE
    - Western blot
    - 2D electrophoresis
    - SEC
    - peptide synthesis
    - MS


interests:
  enable: true
  title: Interests
  list:
  - retrogaming
  - electronics
  - DIY and gardening
  - half-marathon
  - tennis
  - hiking